Hostname: page-component-77c89778f8-swr86 Total loading time: 0 Render date: 2024-07-20T05:42:57.714Z Has data issue: false hasContentIssue false

Producing Standards, Producing the Nordic Region: Antibiotic Susceptibility Testing, from 1950–1970

Published online by Cambridge University Press:  29 April 2014

Anne Kveim Lie*
Affiliation:
University of Oslo, OsloNorway Email: ahlie@medisin.uio.no

Argument

During the 1950s it became apparent that antibiotics could not conquer all microbes, and a series of tests were developed to assess the susceptibility of microbes to antibiotics. This article explores the development and standardization of one such testing procedure which became dominant in the Nordic region, and how the project eventually failed in the late 1970s. The standardization procedures amounted to a comprehensive scheme, standardizing not only the materials used, but also the methods and the interpretation of the results. Focusing on Sweden and Norway in particular, the article shows how this comprehensive standardization procedure accounted for several co-dependent factors and demanded collaboration within and across laboratories. Whereas literature on standardization has focused mostly on how facts and artefacts move within and across laboratories, I argue for the importance of also attending to regions and territories. More particularly, while arguing that the practices, ideals, and politics related to what have been called the “Nordic welfare state” were contributing to the design of the standardized procedure in the laboratory, I also argue that Scandinavia was drawn together as a unified region with and by these very same practices.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

AB Biodisk. 1972. “AB Biodisk annual report 1967–72.”Google Scholar
AB Biodisk. 1975.Google Scholar
Alestig, Kjell, Bertler, Åke, Brorson, John-Erik, Burman, Lars G, Dornbusch, Katherine, Ericson, Carl, Kallings, Lars-Olof, Kamme, Carl, Malmborg, Anna Stina, Nordbring, Folke, Norrby, Ragnar, Olsson-Liljequist, Barbro, and Wallmark, Gösta. 1981. “A Revised System for Antibiotic Sensitivity Testing.” Scandinavian Journal of Infectious Diseases 13:148–52.Google Scholar
Andersen, Bent Rold. 1986. “Rationality and Irrationality of the Nordic Welfare State.” In Norden:The Passion for Equality, edited by Graubard, Stephen R., 117–21. Oslo: Norwegian University Press.Google Scholar
Arvidson, Staffan, Dornbusch, Katherine, and Ericsson, Hans. 1981. “Interpretation of the Agar Diffusion Method for Bacterial Susceptibility Testing.” Journal of Antimicrobial Chemotherapy 7 (1):514.CrossRefGoogle ScholarPubMed
Asdal, Kristin. 2004. Politikkens teknologier: produksjoner av regjerlig natur [The Technologies of Politics: Productions of Governable Nature]. Oslo: Det humanistiske fakultet, Universitetet i Oslo.Google Scholar
Asdal, Kristin. 2008. “Enacting Things through Numbers: Taking Nature into Account/ing.” Geoforum 39 (1):123132.CrossRefGoogle Scholar
Barnes, John Arundel. 1954. “Class and Committees in a Norwegian Island Parish.” Human Relations 7:3958.CrossRefGoogle Scholar
Barry, Arthur. 1989. “Standardization of Antimicrobial Susceptibility Testing.” Clinics in Laboratory Medicine 9 (2):203219.CrossRefGoogle ScholarPubMed
Alfred, Bauer, Kirby, William, Sherris, John C., Turck, Marvin. 1966. “Antibiotic Susceptibility Testing by a Standardized Single Disk Method.” American Journal of Clinical Pathology 45:493496.Google Scholar
Berg, Siv Frøydis. 2002. Den unge Karl Evang og utvidelsen av helsebegrepet: en idéhistorisk fortelling om sosialmedisinens fremvekst i norsk mellomkrigstid [The Young Karl Evang and the Expansion of the Concept of Health: An Intellectual History of the Growth of Social Medicine in the Interwar Period in Norway]. Oslo: Solum.Google Scholar
Bergan, Tom, Asbjørn, Digranes, and Kjetil, Melby. 1996. Norwegian Working Group on Antibiotics: Susceptibility Testing of Bacteria and Fungi. Scandinavian Journal of Infectious Diseases, Supplementum, vol. 3. Basingstoke: Taylor & Francis.Google Scholar
Bonah, Christian. 2010. “‘We need for digitalis preparations what the state has established for serumtherapy. . .’: From Collecting Plants to International Standardization: The Case of Strophanthin, 1900–1938.” In Evaluating and Standardizing Therapeutic Agents, 1890–1950, edited by Gradmann, Christoph and Simon, Jonathan, 202229. Basingstoke: Palgrave Macmillan.CrossRefGoogle Scholar
Boundy, C., and Munch-Petersen, Erik. 1962. “Yearly Incidence of Penicillin-Resistant Staphylococci in Man since 1942.” Bulletin of the World Health Organization 26:241252.Google Scholar
Bowie, J. H., and Gould, J. C.. 1952. “Colouring Agents for Use in Disc-Antibiotic Sensitivity Tests.” Journal of Clinical Pathology 5 (4):356–8.CrossRefGoogle ScholarPubMed
Bøvre, Kjell. 1962. “Bakteriologiske resistensbestemmelser” [Bacteriological Sensitivity Tests]. Tidsskrift for den norske legeforening [Journal for the Norwegian Medical Association] 82:210213.Google Scholar
Branch, Arnold, Starkey, D. H., and Rodgers, K. C.. 1955. “Experience with Controlling Antibiotic Sensitivity Tests in Department of Veterans Affairs Hospital Laboratories in Canda.” In Antibiotics Annual 1954–55, 1125. New York: Medical Encyclopedia.Google Scholar
Branch, Arnold, Starkey, D. H., and Power, Edna E.. 1959. “The Present Status of Control of Manufactured Antibiotic Sensitivity Discs.” Canadian Medical Association Journal 81:175–83.Google ScholarPubMed
Bud, Robert. 1991. “Biotechnology in the Twentieth Century.” Social Studies of Science 21 (3):415457.CrossRefGoogle ScholarPubMed
Bud, Robert. 1993. The Uses of Life: A History of Biotechnology. Cambridge: Cambridge University Press.Google Scholar
Bud, Robert. 2007. Penicillin: Triumph and Tragedy. Oxford: Oxford University Press.Google Scholar
Cambrosio, Alberto. 2010. “Standardization before Biomedicine: On Early Forms of Regulatory Objectivity.” In Evaluating and Standardizing Therapeutic Agents, 1890–1950, edited by Gradmann, Christoph and Simon, Jonathan, 252–62. Basingstoke NY: Palgrave Macmillan.CrossRefGoogle Scholar
Carpenter, Daniel. 2010, Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton: Princeton University Press.Google Scholar
Clarke, Adele E., and Fujimura, Joan H., eds. 1992. The Right Tools for the Job: At Work in Twentieth-Century Life Sciences. Princeton NJ: Princeton University Press.CrossRefGoogle Scholar
Delhey, Jan, and Newton, Kenneth. 2005. “Predicting Cross-National Levels of Social Trust: Global Pattern or Nordic Exceptionalism?European Sociological Review 21 (4):311327.CrossRefGoogle Scholar
Digranes, Asbjørn. 2011. Interview by the author, April 13.Google Scholar
Dølvik, Jon Erik. 2007. The Nordic Regimes of Labour Market Governance: From Crisis to Success Story? Fafos Rådsprogram 2006–2008 [The Program for the Council 2006–2008]. Oslo: FAFO.Google Scholar
Dyrdal, Morten. 2001. Nasjonale legemiddelregimer for fall: en komparativ studie av nordiske legemiddelregimers Europatilpasning [The Decline of National Drug Regimes: A Comparative Study of the Adaptation of Nordic Drug Regimes to Europe]. Bergen: LOS-Senteret.Google Scholar
Dyrdal, Morten. 2002. “Legemiddelregimer mellom helse og marked” [Drug Regimes between Health and Market]. Norsk farmaceutisk tidsskrift [Norwegian Journal of Pharmacy] 6:2123.Google Scholar
Dyrdal, Morten. 2004. Legemiddeltilsyn og europeisering [Medicines control and Europeanization], vol. 10. Notat [Memorandum]. Bergen: Senteret.Google Scholar
Editorial. 1974. “The Disc Sensitivity Test.” British Medical Journal 3 (5923):74–5.Google Scholar
Ehn, Billy, Frykman, Jonas, and Löfgren, Orvar. 1993. Försvenskningen av Sverige: det nationellas förvandlingar [Swedishization of Sweden: The Transfomation of the National]. Stockholm: Natur och Kultur.Google Scholar
Ericsson, Hans. 1946. “Purification and Adsorption of Diphtheria Toxoid.” Nature 158:350–51.CrossRefGoogle ScholarPubMed
Ericsson, Hans. 1960a. Rational Use of Antibiotics in Hospitals: Studies on Laboratory Methods and Discussion of the Biological Basis for their Clinical Application. Scandinavian Journal of Clinical & Laboratory Investigation, Supplement, vol. 50. Oxford: Published for Medisinsk fysiologisk forenings forlag by Blackwell Scientific Publications.Google Scholar
Ericsson, Hans. 1960b. “The Paper Disc Method for Determination of Bacterial Sensitivity to Antibiotics. Studies on the Accuracy of the Technique.” Scandinavian Journal of Clinical and Laboratory Investigation 12:408–13.CrossRefGoogle ScholarPubMed
Ericsson, Hans, ed. 1964. Standardization of Methods for Conducting Microbic Sensitivity Tests. Preliminary Report of a Working Group of the International Collaborative Study Sponsored by the World Health Organization. Stockholm: Karolinska sjukhuset.Google Scholar
Ericsson, Hans. 1974. “Letter: The Disc Sensitivity Test.” British Medical Journal 3 (5934):805–6.CrossRefGoogle ScholarPubMed
Ericsson, Hans, Erlanson, Per, Tunevall, Gösta, and Wallmark, Gösta. 1953. “Bestämning av bakteriers kemoresistens. Principiella synpunkter på dess utförande och bedömande” [Analysis of the Chemical Resistance of Bacteria. Principal Points of View on their Execution and Discrimination]. Svenska Läkartidningen [Journal for the Swedish Medical Association] 50:476–81.Google Scholar
Ericsson, Hans, and Ericsson, Magnus, eds. 1975. Minnesanteckningar från konferensen Planerad och kontrollerad antibioticaterapi [Minutes from the Conference on Planned and Controlled Antibiotic Treatment]. Stockholm: AB Biodisk.Google Scholar
Ericsson, Hans, Hogman, Claes, and Wickman, Kristina. 1954. “A Paper Disk Method for Determination of Bacterial Sensitivity to Chemotherapeutic and Antibiotic Agents.” Scandinavian Journal of Clinical & Laboratory Investigation 6 (Supplement 11):2336.Google ScholarPubMed
Ericsson, Hans, and Löfström, Gunnar. 1952. “Del I. Bakteriologi” [Part 1. Bacteriology]. In Kliniska laborationsmetoder [Clinical Laboratory Methods], edited by Hammarsten, Greta, 7 b. Södertälje: Astra.Google Scholar
Ericsson, Hans, and Sherris, John C.. 1971. “Antibiotic Sensitivity Testing: Report of an International Collaborative Study.” Acta pathologica et microbiologica Scandinavica, Supplement 67. Copenhagen: Munksgaard.Google Scholar
Ericsson, Magnus. 2011. Interview by the author, November 29.Google Scholar
Erlanson, Per. 1951. Determination of the Sensitivity in vitro of Bacteria to Chemotherapeutic Agents: with Special Reference to Routine Tests. Vol. 85, Acta pathologica et microbiologica Scandinavica, Supplement. Copenhagen: Munksgaard.Google Scholar
Esping-Andersen, Gösta. 1990. The Three Worlds of Welfare Capitalism. Cambridge: Polity Press.Google Scholar
Expert Committee on Antibiotics. 1961. Standardization of Methods for Conducting Microbic Sensitivity Tests. Second Report of the Expert Committee on Antibiotics. Geneva: World Health Organization.Google Scholar
Expert Committee on Hospital Laboratory Services. 1959. Hospital Laboratory Services: Second Report. Geneva: World Health Organization.Google Scholar
Fairbrother, Robert W., Martyn, G., and Parker, L.. 1951. “The Laboratory Control of Antibiotic Therapy.” Lancet 258 (6682):516519.CrossRefGoogle Scholar
Fleming, Alexander. 1929. “On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. Influenzae.” British Journal of Experimental Pathology 10:226–36.Google Scholar
Fujimura, Joan H. 1996. Crafting Science: A Sociohistory of the Quest for the Genetics of Cancer. Cambridge: Harvard University Press.CrossRefGoogle Scholar
Furniss, Norman, and Tilton, Timothy. 1979. The Case for the Welfare State: From Social Security to Social Equality. Bloomington: Indiana University Press.Google Scholar
Garrod, Lawrence P., and Waterworth, Pamela M.. 1971. “A Study of Antibiotic Sensitivity Testing with Proposals for Simple Uniform Methods.” Journal of Clinical Pathology 24 (9):779–89.CrossRefGoogle ScholarPubMed
Gaudillière, Jean-Paul. 2001. “Beyond the One-Case Statistics: Mathematics, Medicine and the Management of Health and Disease in the Postwar Era.” In Changing Images in Mathematics: From the French Revolution to the New Millenium, edited by Bottazzini, Umberto and Dalmedico, Amy Dahan, 281296. London: Routledge.Google Scholar
Gerhardsen, Einar. 1930. Tillitsmannen: håndbok i praktisk organisasjonsarbeid [The Representative. Manual in Practical Organization Work]. Oslo: Det norske arbeiderparti [The Norwegian Labor Party].Google Scholar
Gossel, Patricia Peck. 1992. “A Need for Standard Methods: The Case of American Bacteriology.” In The Right Tools for the Job, edited by Clarke, Adele E. and Fujimura, Joan H., 77114. Princeton: Princeton University Press.Google Scholar
Gould, J. C., and Bowie, J. H.. 1952. “The Determination of Bacterial Sensitivity to Antibiotics.” Edinburgh Medical Journal 59:178–99.Google ScholarPubMed
Gradmann, Christoph. 2013. “Sensitive Matters. The World Health Organisation and Antibiotic Resistance Testing, 1945–1975.” Social History of medicine 26 (3):555574CrossRefGoogle Scholar
Gullestad, Marianne. 1984. Kitchen-Table Society. Oslo: Scandinavian University Press.Google Scholar
Gullestad, Marianne. 1992. The Art of Social Relations: Essays on Culture, Social Action and Everyday Life in Modern Norway. Oslo: Scandinavian University Press.Google Scholar
Haave, Per. 2006. “The Hospital Sector: A Four-Country Comparison of Organisational and Political Development.” In The Nordic Model of Welfare. A Historical Reappraisal, edited by Christiansen, Niels Finn, Petersen, Klaus, Edling, Nils and Haave, Per, 215242. Museum Tusculanums Forlag.Google Scholar
Haave, Per. Unpublished Paper. “The Welfare State: A Missing Concept in Norwegian Political Language (1945–1965).”Google Scholar
Hambraeus, Anna, Kahlmeter, Gunnar, Malmborg, Anna-Stina, and Nyström, Bertil. 2007. “Developments in the Recent Past: Hospital Hygiene and Antimicrobials.” APMIS (formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica) 115 (5):409414.CrossRefGoogle ScholarPubMed
Hillier, Kathryn. 2006. “Babies and Bacteria: Phage Typing, Bacteriologists, and the Birth of Infection Control.” Bulletin of the History of Medicine 80 (4):733761.CrossRefGoogle ScholarPubMed
Howie, James. 1962. “Recent Developments in Chemotherapy.” Lancet 279 (7240):11371140.CrossRefGoogle Scholar
Jøldal, Bjørn. 1986. “The Evaluation and Control of Drugs in Norway.” International Journal of Technology Assessments in Health Care 2:663672.CrossRefGoogle Scholar
Keating, Peter, and Cambrosio, Alberto. 2003. Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge MA: MIT Press.CrossRefGoogle Scholar
Keating, Peter, Cambrosio, Alberto, and Guttman, Ronald. 1992. “The Tools of the Discipline: Standards, Models and Measures in the Affinity/Avidity Controversy in Immunology.” In The Right Tools for the Job: At Work in Twentieth-Century Life Sciences, edited by Clarke, Adele E. and Fujimura, Joan H., 312–54. Princeton: Princeton University Press.CrossRefGoogle Scholar
Krige, John. 2006. American Hegemony and the Postwar Reconstruction of Science in Europe. Cambridge: MIT Press.CrossRefGoogle Scholar
Kronvall, Göran. 2007a. “A History of the Section for Medical Microbiology within the Swedish Society of Medicine.” APMIS 115 (5):387–391.CrossRefGoogle Scholar
Kronvall, Göran. 2007b. “Commentary (on Hans Ericsson and Biodisk).” APMIS 115 (5):619620.CrossRefGoogle Scholar
Lappverket. n.d. (Folder published by the firm Biodisk). Lappmetodens användning för kvantitativ bestämning av bakteriers känslighet för antibiotica [The Use of the Paper Disc Method in Quantitative Discrimination of the Sensitivity of Bacteria to Antibiotics]. Stockholm: Karolinska sjukhusets kliniskt-bakteriologiska laboratorium.Google Scholar
Latour, Bruno. 1988. The Pasteurization of France. Cambridge: Harvard University Press.Google Scholar
Markkola, Pirjo, and Christiansen, Niels Finn. 2006. “Introduction.” In The Nordic Model of Welfare. A Historical Reappraisal, edited by Christiansen, Niels Finn, Petersen, Klaus, Edling, Nils and Haave, Per, 931. Museum Tusculanums Forlag.Google Scholar
Midtvedt, Tore. 2010. Interview by the author, March 17.Google Scholar
Moen, Kjetil. 1997. Fra monopol til konkurranse: EØS, norsk legemiddelpolitikk og Norsk Medisinaldepot [From Monopoly to Competition: European Economic Area, Norwegian Drug Policy and Norwegian Medicines Agency]. Oslo: Universitetet i Oslo.Google Scholar
Nordby, Trond. 1989. Karl Evang: en biografi [Karl Evang: A Biography]. Oslo: Aschehoug.Google Scholar
Nordby, Trond. 1990. “‘Velferdsstaten’ og ‘den sosialdemokratiske stat’: norske myter i historisk lys” [The “Welfare State” and “The Social Democratic State”: Norwegian Myths in the Light of History]. Sosiologi i dag [Sociology Today] (4):89–107.Google Scholar
Norwegian Department of Social Affairs. 1952. Proposition to the Odelsting (the largest of the two divisions of the Norwegian Parliament), no. 29.Google Scholar
Porter, Theodore M. 1994a. “Making Things Quantitative.” Science in Context 7 (3):389407.CrossRefGoogle Scholar
Porter, Theodore M. 1994b. “Objectivity and Standardization: The Rhetoric of Impersonality in Measurement, Statistics and Cost-Benefit Analysis.” In Rethinking Objectivity, edited by Megill, Allan, 197239. Durham and London: Duke University Press.Google Scholar
Rader, Karen A. 2004. Making Mice: Standardizing Animals for American Biomedical Research, 1900–1955. Princeton: Princeton University Press.CrossRefGoogle Scholar
Referensgruppen för antibiotikafrågor. 1977. Resistensbestämning av bakterier mot antibiotika: Förslag til känslighetsgruppering med mer [Sensitivity Testing of Bacteria against Antibiotics: Suggestions for Grouping of Sensitivity etc] (Asbjørn Digranes personal archive).Google Scholar
Schiøtz, Aina, and Skaset, Maren. 2003. Folkets helse - landets styrke 1850–2003 [The Health of a People – The Strength of a Country 1850–2003]. Oslo: Universitetsforlaget.Google Scholar
Seip, Anne-Lise. 1994. Veiene til velferdsstaten: norsk sosialpolitikk 1920–75 [The Roads to the Welfare State: Norwegian Social Policy 1920–75]. Oslo: Gyldendal.Google Scholar
Sejersted, Francis, Adams, Madeleine B., and Daly, Richard. 2011. The Age of Social Democracy: Norway and Sweden in the Twentieth Century. Princeton: Princeton University Press.CrossRefGoogle Scholar
Shalev, Michael 1983. “The Social-Democratic Model and Beyond: Two ‘Generations’ of Comparative Research on the Welfare State.” Comparative Social Research 6:315–52.Google Scholar
Skirbekk, Helge, and Grimen, Harald. 2012. Tillit i Norge [Trust in Norway]. Oslo: Res Publica.Google Scholar
Steen, Emil. 1955. “Den praktiske verdi av resistensbestemmelser overfor antibakterielle midler” [The Practical Value of Sensitivity Testing towards Antibacterial Drugs]. Nordisk Medicin 54:1269–73.Google Scholar
Thompson, B. A. 1950. “Dried Disc Technique for Determining Sensitivity to the Antibiotics.” Journal of Clinical Pathology 3 (2):118–21.CrossRefGoogle Scholar
Timmermans, Stefan, and Berg, Marc. 1997. “Standardization in Action: Achieving Local Universality through Medical Protocols.” Social Studies of Science 27 (2):273305.CrossRefGoogle Scholar
Titmuss, Richard M., Titmuss, Kay, and Abel-Smith, Brian. 1974. Social Policy: An Introduction. London: George Allen & Unwin.Google Scholar
Trägårdh, Lars. 2009. Tillit i det moderna Sverige: den dumme svensken och andra mysterier [Trust in Modern Sweden: The Stupid Swede and Other Mysteries]. Stockholm: SNS Förlag.Google Scholar
Vincent, James, and Vincent, Helen. 1944. “Filter Paper Disc Modification of the Oxford Cup Penicillin Determination.” Proceedings of the Society for Experimental Biology and Medicine 55:162–4.CrossRefGoogle Scholar
Wollebæk, Dag. 2011. “Norges sosiale kapital i Nordisk og Europeisk kontekst” [Norway's Social Capital in a Nordic and European Context]. In Sosial kapital i Norge [Social Capital in Norway], edited by Wollebæk, Dag and Segaard, Signe B, 5179. Oslo: Cappelen Damm.Google Scholar